Use of Donanemab in Early Symptomatic Alzheimer Disease. Pomara N, Imbimbo BP. JAMA 2023;330:2304.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Pomara N, Imbimbo BP. Use of Donanemab in Early Symptomatic Alzheimer Disease. JAMA 2023;330:2304.
PMID: 38112820